COBEX offers variety of partnerships & alliances when considering opportunities for various kind of products and services. We are well well-versed in many types of these partnerships which include, but not limited to -
COBEX along with its associated companies works with multi-national companies in order to obtain licensing on their internal developments for the US market. These companies do not look to market their own products, and in most cases they do not manufacture. These companies simply acting as a CRO, and look for partners to carry projects beyond formulation & API’s.
The API’s and Formulations can be in any therapeutic category, and any type of delivery system. Further, they can range from a typical generic where -
In the above case scenario we offer the following -
Out-licensing has become a crucial part of most biotech companies' business strategies. Nonetheless, several recent research reports demonstrate that biotech companies can fair better in the current licensing environment. The reports make the argument that biotech companies don't maximize the value of their assets due to inefficient out-licensing processes. To increase shareholder value, biotech companies intending to out-license one or more of their programs must do one of two things. They must either commit to a dedicated internal out-licensing team with a best-practice, out-licensing process and infrastructure that can methodically and proactively present their technology, or they should consider hiring professional assistance from a business development company that can provide its insight, experience, network, and proven processes, allowing management to remain fully engaged and focused on their core operational activities.
COBEX and its associated partners are fully capable to address your outsourcing projects.
TO PROVIDE END TO END PHRAMA LIFE CYCLE SOLUTIONS AND HELP PHARMA
SECTOR TO PRODUCE INNOVATIVE &
QUALITY DRUGS & MEDICINES AT LOW COST FOR THE WELLBEING OF PEOPLE
TO BECOME THE CHOICEST & PREFFERED WORLD
CLASS PARTNERS AND ASSOCIATES TO FASCILITATE DRUG DISCOVERY & MANUFACTURING